Your session is about to expire
← Back to Search
Procedure
Pulsatile blood flow for Acute Kidney Injury
N/A
Waitlist Available
Led By Nathan J Clendenen, MD, MS
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from intensive care unit admission after surgery to hospital discharge, up to 30 days
Awards & highlights
Study Summary
This trial aims to see if using a specific type of blood flow during heart surgery can help reduce the risk of kidney damage. Researchers will also look at how safe and effective this method is compared to the
Who is the study for?
This trial is for patients undergoing cardiac surgery who will be on cardiopulmonary bypass. It's not clear what specific conditions or characteristics make someone eligible or ineligible to participate.Check my eligibility
What is being tested?
The study is testing if pulsatile blood flow (mimicking natural heartbeat rhythms) during cardiopulmonary bypass can reduce kidney damage after heart surgery, compared to non-pulsatile flow (steady stream).See study design
What are the potential side effects?
Potential side effects are not specified, but may include complications related to changes in blood flow during surgery such as increased risk of bleeding, clotting issues, or other impacts on organ function.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from intensive care unit admission after surgery to hospital discharge, up to 30 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from intensive care unit admission after surgery to hospital discharge, up to 30 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acute kidney injury
Secondary outcome measures
30-day mortality
Acute kidney injury risk score
Discontinuation rate of cardiopulmonary bypass mode
+2 moreOther outcome measures
Duration of mechanical ventilation
Intra-operative cryoprecipitate transfusion in units
Intra-operative plasma transfusion in units
+18 moreTrial Design
2Treatment groups
Active Control
Group I: Pulsatile blood flowActive Control1 Intervention
Pulsatile blood flow during cardiopulmonary bypass
Group II: Non-pulsatile blood flowActive Control1 Intervention
Non-pulsatile blood flow during cardiopulmonary bypass
Find a Location
Who is running the clinical trial?
University of Colorado, DenverLead Sponsor
1,739 Previous Clinical Trials
2,149,045 Total Patients Enrolled
7 Trials studying Acute Kidney Injury
439 Patients Enrolled for Acute Kidney Injury
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,841 Previous Clinical Trials
47,813,005 Total Patients Enrolled
9 Trials studying Acute Kidney Injury
3,446 Patients Enrolled for Acute Kidney Injury
Nathan J Clendenen, MD, MSPrincipal InvestigatorUniversity of Colorado, Denver
1 Previous Clinical Trials
66 Total Patients Enrolled
1 Trials studying Acute Kidney Injury
66 Patients Enrolled for Acute Kidney Injury
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Do individuals aged 55 and above meet the criteria for participation in this medical study?
"Enrollment for this research study is open to individuals over 18 years old and under the age of 85."
Answered by AI
Are there any available openings for patients to participate in this medical study?
"Per the details on clinicaltrials.gov, this specific study is not presently accepting applicants. It was initially listed on 4/1/2024 and last revised on 4/4/2024. Despite its current inactivity, it's worth noting that there are currently 1302 other trials actively seeking participants."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger